171 related articles for article (PubMed ID: 28415941)
21. Endothelial Protein C Receptor Gene Variants and Risk of Thrombosis.
Anastasiou G; Politou M; Rallidis L; Grouzi E; Karakitsos P; Merkouri E; Travlou A; Gialeraki A
Clin Appl Thromb Hemost; 2016 Mar; 22(2):199-204. PubMed ID: 25760048
[TBL] [Abstract][Full Text] [Related]
22. The Effects of Endothelial Protein C Receptor Gene Polymorphisms on the Plasma sEPCR Level in Venous Thrombosis Patients.
Karabıyık A; Yılmaz E; Eğin Y; Akar N
Turk J Haematol; 2012 Mar; 29(1):55-62. PubMed ID: 24744624
[TBL] [Abstract][Full Text] [Related]
23. Haplotypes of the EPCR gene, prothrombin levels, and the risk of venous thrombosis in carriers of the prothrombin G20210A mutation.
Navarro S; Medina P; Mira Y; Estellés A; Villa P; Ferrando F; Vayá A; Bertina RM; España F
Haematologica; 2008 Jun; 93(6):885-91. PubMed ID: 18403391
[TBL] [Abstract][Full Text] [Related]
24. PROC, PROCR and PROS1 polymorphisms, plasma anticoagulant phenotypes, and risk of cardiovascular disease and mortality in older adults: the Cardiovascular Health Study.
Reiner AP; Carty CL; Jenny NS; Nievergelt C; Cushman M; Stearns-Kurosawa DJ; Kurosawa S; Kuller LH; Lange LA
J Thromb Haemost; 2008 Oct; 6(10):1625-32. PubMed ID: 18680534
[TBL] [Abstract][Full Text] [Related]
25. The H3 Haplotype of the EPCR Gene Determines High sEPCR Levels in Critically Ill Septic Patients.
Vassiliou AG; Kotanidou A; Mastora Z; Tascini C; Cardinali G; Orfanos SE
Infect Dis Ther; 2018 Mar; 7(Suppl 1):3-14. PubMed ID: 29549653
[TBL] [Abstract][Full Text] [Related]
26. Renal and urinary levels of endothelial protein C receptor correlate with acute renal allograft rejection.
Lattenist L; Kers J; Claessen N; ten Berge IJ; Bemelman FJ; Florquin S; Roelofs JJ
PLoS One; 2013; 8(5):e64994. PubMed ID: 23717683
[TBL] [Abstract][Full Text] [Related]
27. Elevated soluble endothelial protein C receptor levels at ICU admission are associated with sepsis development.
Vassiliou AG; Kotanidou A; Mastora Z; Maniatis NA; Albani P; Jahaj E; Koutsoukou A; Armaganidis A; Orfanos SE
Minerva Anestesiol; 2015 Feb; 81(2):125-34. PubMed ID: 25220546
[TBL] [Abstract][Full Text] [Related]
28. Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study.
Tinholt M; Viken MK; Dahm AE; Vollan HK; Sahlberg KK; Garred O; Børresen-Dale AL; Jacobsen AF; Kristensen V; Bukholm I; Kåresen R; Schlichting E; Skretting G; Lie BA; Sandset PM; Iversen N
BMC Cancer; 2014 Nov; 14():845. PubMed ID: 25407022
[TBL] [Abstract][Full Text] [Related]
29. Endothelial protein C receptor expressed by ovarian cancer cells as a possible biomarker of cancer onset.
Ducros E; Mirshahi S; Azzazene D; Camilleri-Broët S; Mery E; Al Farsi H; Althawadi H; Besbess S; Chidiac J; Pujade-Lauraine E; Therwath A; Soria J; Mirshahi M
Int J Oncol; 2012 Aug; 41(2):433-40. PubMed ID: 22614534
[TBL] [Abstract][Full Text] [Related]
30. Endothelial protein C receptor gene 6936A/G single-nucleotide polymorphism as a possible biomarker of thrombotic risk in acute myeloid leukemia.
Besbes S; Althawadi H; Alfarsi H; Mirshahi S; Tang R; Fava F; Pardo J; Huessler EM; Galtier T; Ghedira I; Soria J; Marie JP; Mirshahi M
Mol Clin Oncol; 2015 Nov; 3(6):1280-1284. PubMed ID: 26807233
[TBL] [Abstract][Full Text] [Related]
31. Alternative mRNA is favored by the A3 haplotype of the EPCR gene PROCR and generates a novel soluble form of EPCR in plasma.
Saposnik B; Lesteven E; Lokajczyk A; Esmon CT; Aiach M; Gandrille S
Blood; 2008 Apr; 111(7):3442-51. PubMed ID: 18073349
[TBL] [Abstract][Full Text] [Related]
32. Targeted gene sequencing identifies variants in the protein C and endothelial protein C receptor genes in patients with unprovoked venous thromboembolism.
Wu C; Dwivedi DJ; Pepler L; Lysov Z; Waye J; Julian J; Desch K; Ginsburg D; Weitz JI; Kearon C; Liaw PC
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2674-81. PubMed ID: 24051141
[TBL] [Abstract][Full Text] [Related]
33. Three polymorphisms in promoter of protein C gene with endothelial protein c receptor gene and risk of venous thrombosis.
Horakova K; Kolorz M; Bartosova L; Pechacek V; Wroblova K
Blood Coagul Fibrinolysis; 2013 Dec; 24(8):814-7. PubMed ID: 24158116
[TBL] [Abstract][Full Text] [Related]
34. Genetic association between cluster of differentiation 86 variations and sepsis risk: A case-control study.
Zou X; Cai J; Li B; Wu S
Medicine (Baltimore); 2019 Oct; 98(43):e17482. PubMed ID: 31651850
[TBL] [Abstract][Full Text] [Related]
35. [Relationship between endothelial protein C receptor gene 6936A/G polymorphisms and deep venous thrombosis].
Chen XD; Tian L; Zheng CF; Li M; Jin W; Wang XH; Pan SL
Zhonghua Xue Ye Xue Za Zhi; 2010 Sep; 31(9):607-9. PubMed ID: 21122321
[TBL] [Abstract][Full Text] [Related]
36. Endothelial cell protein C receptor gene 6936A/G polymorphism is associated with venous thromboembolism.
Yin G; Jin X; Ming H; Zheng X; Zhang D
Exp Ther Med; 2012 Jun; 3(6):989-992. PubMed ID: 22970004
[TBL] [Abstract][Full Text] [Related]
37. Association of Transforming Growth Factor β1 Gene Polymorphisms and Inflammatory Factor Levels with Susceptibility to Sepsis.
Zheng R; Fu Z; Zhao Z
Genet Test Mol Biomarkers; 2021 Mar; 25(3):187-198. PubMed ID: 33734893
[No Abstract] [Full Text] [Related]
38. Failure to validate association of gene polymorphisms in EPCR, PAR-1, FSAP and protein S Tokushima with venous thromboembolism among Californians of European ancestry.
Pecheniuk NM; Elias DJ; Xu X; Griffin JH
Thromb Haemost; 2008 Feb; 99(2):453-5. PubMed ID: 18278202
[No Abstract] [Full Text] [Related]
39. EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro.
Ireland H; Konstantoulas CJ; Cooper JA; Hawe E; Humphries SE; Mather H; Goodall AH; Hogwood J; Juhan-Vague I; Yudkin JS; di Minno G; Margaglione M; Hamsten A; Miller GJ; Bauer KA; Kim YT; Stearns-Kurosawa DJ; Kurosawa S
Atherosclerosis; 2005 Dec; 183(2):283-92. PubMed ID: 15921688
[TBL] [Abstract][Full Text] [Related]
40. Plasma endothelial protein C receptor influences innate immune response in ovarian cancer by decreasing the population of natural killer and TH17 helper cells.
Azzazene D; Al Thawadi H; Al Farsi H; Besbes S; Geyl C; Mirshahi S; Pardo J; Faussat AM; Jeannette S; Therwath A; Pujade-Lauraine E; Mirshahi M
Int J Oncol; 2013 Oct; 43(4):1011-8. PubMed ID: 23877403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
